Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
Key Information
Due Date: October 17, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant, Government
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes grant (R03 Clinical Trial Not Allowed) is a Funding Opportunity Announcement (FOA) that invites researchers to apply for funding for clinical projects designed to prepare for clinical trials in rare diseases. By supporting such projects, this initiative aims to streamline the process of getting potential therapeutics or diagnostic tools to clinical trials. This can be achieved by creating rigorous biomarkers and clinical outcome assessment measures or by defining the characteristics and progression of a rare disease in order to plan for future clinical trials. Through this grant, researchers will have an enhanced chance of success in the development and testing phases related to rare disease research.
Show More
Key Dates
Open Date: April 13, 2023
Application Due Date: October 17, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses